Skip to content

Turn Therapeutics Inc.

TTRX

CIK 0002023016

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$3.87M
−80.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.14
−71.4% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$11.01M
Q1 May 2026
Total Debt
$5.94M
Q1 May 2026
Shares Outstanding
29.79M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings